Page last updated: 2024-10-18

dimethylglycine and Alzheimer Disease

dimethylglycine has been researched along with Alzheimer Disease in 1 studies

dimethylglycine: metabolic product of calcium pangamate; mutagen when mixed with nitrite; RN given refers to parent cpd
N,N-dimethylglycine : An N-methylglycine that is glycine carrying two N-methyl substituents.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, G1
Zhou, Y1
Huang, FJ1
Tang, HD1
Xu, XH1
Liu, JJ1
Wang, Y1
Deng, YL1
Ren, RJ1
Xu, W1
Ma, JF1
Zhang, YN1
Zhao, AH1
Chen, SD1
Jia, W1

Other Studies

1 other study available for dimethylglycine and Alzheimer Disease

ArticleYear
Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.
    Journal of proteome research, 2014, May-02, Volume: 13, Issue:5

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arachidonic Acid; Biomarkers; Chromatography, Liquid; Co

2014